CALGARY, AB, May 26, 2022 /PRNewswire/ – Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) (“Nanalysis” or the “Company”) announces that the Company’s wholly-owned subsidiary K'(Prime) Technologies (KPrime) has won a six year $160 million service and maintenance contract with…
Source: www.prnewswire.com – Read more
How Automation is Advancing Biosimilar Adoption
Many Americans are struggling with the high costs of biologic medications. Although biosimilars, which are cheaper alternatives, exist, they remain underused due to a lack
